Comparative Study of Two Sclerosants for Pleurodesis for Incurable Pleural Effusions and Pneumothorax
| Autor: | M. C. Ikpe, E. E. Ekpe |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Thorax
medicine.medical_specialty Environmental Engineering Cyclophosphamide Pleural effusion business.industry medicine.medical_treatment medicine.disease Industrial and Manufacturing Engineering Surgery Primary outcome Pharmacotherapy Pneumothorax medicine business Prospective cohort study Pleurodesis medicine.drug |
| Zdroj: | British Journal of Medicine and Medical Research. 10:1-9 |
| ISSN: | 2231-0614 |
| Popis: | Background: Pleurodesis is indicated in thoracic pathologies associated with pleural effusions or pneumothoraces resulting from incurable diseases and therefore risked with high chance of recurrence Objective: To compare the success rates of the oral forms of tetracycline and injectable form of cyclophosphamide as chemical pleurodesants in clinical practice. Materials and Methods: Prospective study. Results: There were 33 patients who underwent pleurodesis of 40 pleural spaces (bilateral in 7 patients) M: F=1:2.3 (10 vs 23) Age range: 15-80 years (mean= 49 years). The primary outcome measure was taken at four weeks post pleurodesis. This was the success rate of the pleurodesis which was taken as non-recurrence of pleural effusion or pneumothorax at four weeks. At one month, 16(80%) of the pleural spaces that underwent pleurodesis with tetracycline hydrochloride |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|